Acrux Limited (ASX:ACR – Get Rating) insider Donald Brumley acquired 1,455,000 shares of Acrux stock in a transaction that occurred on Thursday, March 9th. The stock was purchased at an average cost of A$0.06 ($0.04) per share, for a total transaction of A$91,665.00 ($61,520.13).
Donald Brumley also recently made the following trade(s):
Get
Acrux alerts:
- On Wednesday, March 1st, Donald Brumley 138,187 shares of Acrux stock.
Acrux Price Performance
The company has a quick ratio of 2.89, a current ratio of 2.55 and a debt-to-equity ratio of 33.19.
About Acrux
(Get Rating)
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone.
Recommended Stories
- Oracle Has Spoken: Shares Fall 5%
- Just the Catalyst NIO Investors Needed
- FuelCell Energy Gains Traction, Shares Surge
- Solo Brands May Remind Investors Why Cash is King
- Someone Is Buying The Dip In MongoDB
Receive News & Ratings for Acrux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acrux and related companies with MarketBeat.com's FREE daily email newsletter.
Acrux Limited(ASX:ACR-GET Rating)內部人士Donald Brumley在3月9日星期四的一筆交易中收購了1,455,000股Acrux股票。這只股票是以每股0.06澳元(0.04美元)的平均成本購買的,總交易金額為91,665.00澳元(61,520.13美元)。
唐納德·布倫利最近還進行了以下交易:
到達
Acrux警報:
- 3月1日,星期三,唐納德·布倫利購買了138,187股Acrux股票。
Acrux性價比
該公司的速動比率為2.89,流動比率為2.55,債務權益比為33.19。
關於Acrux
(獲取評級)
Acrux有限公司及其子公司在澳大利亞、歐洲、美國和國際上開發和銷售仿製藥和局部藥物。該公司提供睪酮解決方案,如口服片劑、口腔片劑、皮下微丸、透皮貼片、注射和局部凝膠,用於治療睪丸素水準低或沒有的成年男性。
推薦故事
- 甲骨文已表示:股價下跌5%
- 蔚來正是投資者所需的催化劑
- FuelCell Energy獲得牽引力,股價飆升
- 獨家品牌可能提醒投資者為什麼現金為王
- 有人在購買MongoDB中的Dip
接受Acrux Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收Acrux和相關公司的最新新聞和分析師評級的每日簡明摘要。